These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29956143)

  • 1. Induction and Characterization of the Allergic Eye Disease Mouse Model.
    Reyes NJ; Mathew R; Saban DR
    Methods Mol Biol; 2018; 1799():49-57. PubMed ID: 29956143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities.
    Leonardi A; De Dominicis C; Motterle L
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):429-35. PubMed ID: 17873584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease.
    Smith RE; Reyes NJ; Khandelwal P; Schlereth SL; Lee HS; Masli S; Saban DR
    J Leukoc Biol; 2016 Aug; 100(2):371-80. PubMed ID: 26856994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lirentelimab for severe and chronic forms of allergic conjunctivitis.
    Anesi SD; Tauber J; Nguyen QD; Chang P; Berdy GJ; Lin CC; Chu DS; Levine HT; Fernandez AD; Roy N; Asbell PA; Kantor AM; Chang AT; Singh B; Youngblood BA; Jeng BH; Jhanji V; Rasmussen HS; Foster CS
    J Allergy Clin Immunol; 2022 Sep; 150(3):631-639. PubMed ID: 35390403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular allergies.
    Fonacier L; Luchs J; Udell I
    Curr Allergy Asthma Rep; 2001 Jul; 1(4):389-96. PubMed ID: 11892063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of allergic and inflammatory conjunctivitis.
    Groneberg DA; Bielory L; Fischer A; Bonini S; Wahn U
    Allergy; 2003 Nov; 58(11):1101-13. PubMed ID: 14616119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.
    Bielory L; Katelaris CH; Lightman S; Naclerio RM
    MedGenMed; 2007 Aug; 9(3):35. PubMed ID: 18092041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular allergy: implications for the clinical immunologist.
    Katelaris CH
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6 Suppl 3):23-7. PubMed ID: 12839109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Knowledge in Allergic Conjunctivitis.
    Villegas BV; Benitez-Del-Castillo JM
    Turk J Ophthalmol; 2021 Feb; 51(1):45-54. PubMed ID: 33631915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ocular mast cells.
    Church MK; McGill JI
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):419-22. PubMed ID: 12582326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic conjunctivitis in children].
    Zepeda Ortega B; Rosas Vargas MA; Ito Tsuchiya FM; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2007; 54(2):41-53. PubMed ID: 17542245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of ocular allergy.
    Hodges MG; Keane-Myers AM
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):424-8. PubMed ID: 17873583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-C chemokine receptor 6 (CCR6) is crucial for Th2-driven allergic conjunctivitis.
    Chung SH; Chang SY; Lee HJ; Choi SH
    Clin Immunol; 2015 Dec; 161(2):110-9. PubMed ID: 26307432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-phase reaction in ocular allergy.
    Choi SH; Bielory L
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):438-44. PubMed ID: 18769198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.
    Fujishima H; Okada N; Matsumoto K; Fukagawa K; Igarashi A; Matsuda A; Ono J; Ohta S; Mukai H; Yoshikawa M; Izuhara K
    J Allergy Clin Immunol; 2016 Aug; 138(2):459-467.e2. PubMed ID: 26964692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye.
    Fukuda K; Kishimoto T; Sumi T; Yamashiro K; Ebihara N
    Allergol Int; 2023 Apr; 72(2):234-244. PubMed ID: 36333219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of ocular allergy: current thinking.
    Foster CS
    Allergy; 1995; 50(21 Suppl):6-9; discussion 34-8. PubMed ID: 7785749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergy and the eye.
    Leonardi A; Motterle L; Bortolotti M
    Clin Exp Immunol; 2008 Sep; 153 Suppl 1(Suppl 1):17-21. PubMed ID: 18721324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.